Repros Therapeutics, Inc. (RPRX) Posts Narrower than Expected Q3 Loss
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $59.45 +1.45%
Financial Fact:
General and administrative: 997K
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
General and administrative: 997K
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q3 loss of ($0.32), $0.03 better than the analyst estimate of ($0.35).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance
- Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
